Overview

Phase IIB Pilot of Atazanavir + Raltegravir

Status:
Terminated

Trial end date:
2010-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if the combination of atazanavir and raltegravir taken together is safe and effective in the treatment of human immunodeficiency virus (HIV).

Phase:

Phase 2

Details

Lead Sponsor:

Bristol-Myers Squibb

Collaborator:

Merck Sharp & Dohme Corp.

Treatments:

Atazanavir Sulfate
Emtricitabine
Raltegravir Potassium
Ritonavir
Tenofovir